On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Importance of India in global TB control
- 8.8 million incident cases of TB in 2010
- India accounted for 25% of this TB burden
- No country has more cases of TB than India
- TB control in India: what has been accomplished?
- TB control in India is the RNTCP responsibility
- RNTCP: achievements
- RNTCP has made the most of existing toolbox
- TB control in India has been cost-effective
- Challenges for TB control after DOTS scale-up
- Very slow decline in TB incidence
- What factors may explain this?
- Threat of drug-resistant TB
- What does "TDR-TB" really indicate?
- Mismanagement of TB in India
- RNTCP limited capacity to deal with MDR-TB
- TB diagnostic practices in the private sector
- WHO has warned against inaccurate TB tests
- Widespread use of serological tests for TB
- Survey: 17 of 22 use these antibody tests
- Why inaccurate TB tests used in India?
- Root causes for popularity of serology in India
- Government of India banned TB serology tests
- Treatment deviates from international standards
- TB drugs are very available
- Impact of TB mismanagement
- A typical TB patient in India
- New vision and goals for TB control
- What is the new vision for TB control?
- Raising the level of ambition: universal access
- The RNTCP will pursue the following approaches
- Universal access via improved, early diagnosis
- Media campaign
- Replacing bad with WHO-endorsed tests
- Engaging to replace serology with WHO-tools
- Improve notification of TB cases
- For the new vision to succeed, India needs
- How can India contribute to global TB control?
- India's economic growth
- India's progress in science
- India's progress in communications
- Success story with generic drugs and vaccines
- India is poised to take the lead in TB diagnostics
- Creating an ecosystem for innovation
- India can also provide leadership in research
- India's TB control will impact on global TB control
- BRICS are now poised to provide new leadership
- Thank you for listening
Topics Covered
- Importance of India in global TB control
- Burden of TB in India
- Challenges for TB control in India
- New vision and goals for TB control in India
- How can India contribute to global TB control?
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Pai, M. (2013, February 28). India: the epicentre of global TB control [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/RWSA9166.Export Citation (RIS)
Publication History
- Published on February 28, 2013
Financial Disclosures
- Dr. Madhukar Pai has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.